Staying compliant with PBS regulations

To ensure PBS claiming practices are compliant, ethical and audit-ready, here’s what every pharmacist should know.

Are GLP-1 RAs becoming lifelong medicines?

A recent systematic review has reignited debate about what happens when patients stop taking GLP-1 RAs and related incretin therapies.

Pharmacies destroyed and forced to close due to floods

As east coast residents wait for the floods to subside, pharmacists discuss the devastating impact on their homes, pharmacies and patients.

Pharmacists and Australia’s COVID-19 vaccination policy

Pharmacies are likely to play a role in COVID-19 vaccination, and people at  increased risk of exposure, including health and aged care workers, will be among the first to receive a vaccine.

Responding to concerns about paracetamol use in pregnancy

As US regulators flag new warnings on paracetamol use, the TGA and Australian experts have weighed in on what the evidence shows.

Naloxone nasal spray added to the PBS

With increasing overdose deaths from both prescription opioids and heroin, naloxone nasal spray – now listed on the Pharmaceutical Benefits Scheme – is a...